...
首页> 外文期刊>Journal of Medicinal Chemistry >Structure-Affinity Relationships of 2,3,4,5-Tetrahydro-1H-3-benzazepine and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-7-amine Analogues and the Discovery of a Radiofluorinated 2,3,4,5-Tetrahydro-1H-3-benzazepine Congener for Imaging GluN2B Subunit-Containing N-Methyl-D-aspartate Receptors
【24h】

Structure-Affinity Relationships of 2,3,4,5-Tetrahydro-1H-3-benzazepine and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-7-amine Analogues and the Discovery of a Radiofluorinated 2,3,4,5-Tetrahydro-1H-3-benzazepine Congener for Imaging GluN2B Subunit-Containing N-Methyl-D-aspartate Receptors

机译:2,3,4,5-四氢-1H-3-苯并嗪和6,7,8,9-四羟基-5H-苯并[7] Annulen-7-胺类似物的结构 - 亲和力关系和6,7,8,9-四氢-5H-苯并[7] ,用于成像GLUN2B亚甲基-D-天冬氨酸受体的3,4,5-四氢-1H-3-苯并Z-Benzazepine Congener

获取原文
获取原文并翻译 | 示例
           

摘要

Aspiring to develop a positron emission tomography (PET) imaging agent for the GluN2B subunits of the N-methyl-D-aspartate receptor (NMDAR), a key therapeutic target for drug development toward several neurological disorders, we synthesized a series of 2,3,4,5-tetrahydro-1H-3-benzazepine and 6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-amine analogues. After in vitro testing via competition binding assay and autoradiography, [F-18]PF-NB1 emerged as the best performing tracer with respect to specificity and selectivity over sigma 1 and sigma 2 receptors and was thus selected for further in vivo evaluation. Copper-mediated radiofluorination was accomplished in good radiochemical yields and high molar activities. Extensive in vivo characterization was performed in Wistar rats comprising PET imaging, biodistribution, receptor occupancy, and metabolites studies. [F-18]PF-NB1 binding was selective to GluN2B-rich forebrain regions and was specifically blocked by the GluN2B antagonist, CP-101,606, in a dose-dependent manner with no brain radiometabolites. [F-18]PF-NB1 is a promising fluorine-18 PET tracer for imaging the GluN2B subunits of the NMDAR and has utility for receptor occupancy studies.
机译:为N-甲基d天冬氨酸受体(NMDAR),用于药物开发的朝向几个神经病症的关键治疗靶的GluN2B亚基渴望开发一种正电子发射断层摄影(PET)成像剂,我们合成了一系列的2,3 ,4,5-四氢-1H-3-苯并氮杂和6,7,8,9-四氢-5H-苯并[7]轮烯-7-胺的类似物。通过竞争结合测定和放射自显影在体外测试后,[F-18] PF-NB1成为表现最佳的示踪剂超过西格玛1和sigma 2受体对于特异性和选择性从而被选择用于进一步的体内评价。铜介导的放射性氟化在良好的放射化学的产量和高摩尔活动来完成。广泛的体内表征在Wistar大鼠中包含PET成像,生物分布,受体占有率和代谢物的研究进行的。 [F-18] PF-NB1结合是选择性的GluN2B富前脑区域,并具体由GluN2B拮抗剂阻断,CP-101,606,在与无脑radiometabolites以剂量依赖性的方式。 [F-18] PF-NB1是一种很有前途氟-18 PET示踪剂用于成像NMDAR的GluN2B亚基,并且具有用于受体占据研究效用。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2019年第21期|共21页
  • 作者单位

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Univ Munster Inst Pharmaceut &

    Med Chem Corrensstr 48 D-48149 Munster Germany;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

    Univ Munster Inst Pharmaceut &

    Med Chem Corrensstr 48 D-48149 Munster Germany;

    Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号